nodes	percent_of_prediction	percent_of_DWPC	metapath
Goserelin—Lupus-like syndrome—Dapsone—leprosy	0.0651	0.0651	CcSEcCtD
Goserelin—Mental state abnormal—Thalidomide—leprosy	0.058	0.058	CcSEcCtD
Goserelin—Application site reaction—Dapsone—leprosy	0.0327	0.0327	CcSEcCtD
Goserelin—Lymphoedema—Thalidomide—leprosy	0.0322	0.0322	CcSEcCtD
Goserelin—Cerebral ischaemia—Thalidomide—leprosy	0.0162	0.0162	CcSEcCtD
Goserelin—Peripheral vascular disorder—Thalidomide—leprosy	0.016	0.016	CcSEcCtD
Goserelin—Transient ischaemic attack—Thalidomide—leprosy	0.0156	0.0156	CcSEcCtD
Goserelin—Sexual dysfunction—Thalidomide—leprosy	0.014	0.014	CcSEcCtD
Goserelin—Febrile neutropenia—Thalidomide—leprosy	0.0131	0.0131	CcSEcCtD
Goserelin—Deep vein thrombosis—Thalidomide—leprosy	0.0129	0.0129	CcSEcCtD
Goserelin—Galactorrhoea—Thalidomide—leprosy	0.0121	0.0121	CcSEcCtD
Goserelin—Seborrhoeic dermatitis—Thalidomide—leprosy	0.0115	0.0115	CcSEcCtD
Goserelin—Hypercalcaemia—Thalidomide—leprosy	0.0113	0.0113	CcSEcCtD
Goserelin—Metrorrhagia—Thalidomide—leprosy	0.011	0.011	CcSEcCtD
Goserelin—Hyperlipidaemia—Thalidomide—leprosy	0.0109	0.0109	CcSEcCtD
Goserelin—Psychotic disorder—Dapsone—leprosy	0.0109	0.0109	CcSEcCtD
Goserelin—Amblyopia—Thalidomide—leprosy	0.0102	0.0102	CcSEcCtD
Goserelin—Influenza—Dapsone—leprosy	0.00962	0.00962	CcSEcCtD
Goserelin—Endocrine disorder—Thalidomide—leprosy	0.00947	0.00947	CcSEcCtD
Goserelin—Acne—Thalidomide—leprosy	0.00933	0.00933	CcSEcCtD
Goserelin—Amenorrhoea—Thalidomide—leprosy	0.00894	0.00894	CcSEcCtD
Goserelin—Vasodilation—Thalidomide—leprosy	0.00894	0.00894	CcSEcCtD
Goserelin—Vasodilation procedure—Thalidomide—leprosy	0.00894	0.00894	CcSEcCtD
Goserelin—Photosensitivity reaction—Dapsone—leprosy	0.00878	0.00878	CcSEcCtD
Goserelin—Skin discolouration—Thalidomide—leprosy	0.00869	0.00869	CcSEcCtD
Goserelin—Bone disorder—Thalidomide—leprosy	0.00869	0.00869	CcSEcCtD
Goserelin—Arthropathy—Thalidomide—leprosy	0.00864	0.00864	CcSEcCtD
Goserelin—Thinking abnormal—Thalidomide—leprosy	0.00858	0.00858	CcSEcCtD
Goserelin—Herpes simplex—Thalidomide—leprosy	0.00852	0.00852	CcSEcCtD
Goserelin—Hyperuricaemia—Thalidomide—leprosy	0.00847	0.00847	CcSEcCtD
Goserelin—Hypercholesterolaemia—Thalidomide—leprosy	0.0083	0.0083	CcSEcCtD
Goserelin—Bone pain—Thalidomide—leprosy	0.0082	0.0082	CcSEcCtD
Goserelin—Sinusitis—Dapsone—leprosy	0.00805	0.00805	CcSEcCtD
Goserelin—Blood uric acid increased—Thalidomide—leprosy	0.008	0.008	CcSEcCtD
Goserelin—Pulmonary embolism—Thalidomide—leprosy	0.00785	0.00785	CcSEcCtD
Goserelin—Pharyngitis—Dapsone—leprosy	0.00765	0.00765	CcSEcCtD
Goserelin—Dry eye—Thalidomide—leprosy	0.00725	0.00725	CcSEcCtD
Goserelin—Cramps of lower extremities—Thalidomide—leprosy	0.00721	0.00721	CcSEcCtD
Goserelin—Gynaecomastia—Thalidomide—leprosy	0.00703	0.00703	CcSEcCtD
Goserelin—Hypertonia—Thalidomide—leprosy	0.00688	0.00688	CcSEcCtD
Goserelin—Mental disability—Thalidomide—leprosy	0.00681	0.00681	CcSEcCtD
Goserelin—Sepsis—Thalidomide—leprosy	0.00681	0.00681	CcSEcCtD
Goserelin—Erythema—Dapsone—leprosy	0.00671	0.00671	CcSEcCtD
Goserelin—Thrombophlebitis—Thalidomide—leprosy	0.00658	0.00658	CcSEcCtD
Goserelin—Diabetes mellitus—Thalidomide—leprosy	0.00655	0.00655	CcSEcCtD
Goserelin—Vision blurred—Dapsone—leprosy	0.00632	0.00632	CcSEcCtD
Goserelin—Cardiac failure congestive—Thalidomide—leprosy	0.00629	0.00629	CcSEcCtD
Goserelin—Libido decreased—Thalidomide—leprosy	0.00615	0.00615	CcSEcCtD
Goserelin—Increased appetite—Thalidomide—leprosy	0.00607	0.00607	CcSEcCtD
Goserelin—Amnesia—Thalidomide—leprosy	0.00607	0.00607	CcSEcCtD
Goserelin—Cough—Dapsone—leprosy	0.00585	0.00585	CcSEcCtD
Goserelin—Cardiac failure—Thalidomide—leprosy	0.00584	0.00584	CcSEcCtD
Goserelin—Cerebrovascular accident—Thalidomide—leprosy	0.00582	0.00582	CcSEcCtD
Goserelin—Lethargy—Thalidomide—leprosy	0.00582	0.00582	CcSEcCtD
Goserelin—Osteoarthritis—Thalidomide—leprosy	0.0057	0.0057	CcSEcCtD
Goserelin—Disturbance in sexual arousal—Thalidomide—leprosy	0.00566	0.00566	CcSEcCtD
Goserelin—Migraine—Thalidomide—leprosy	0.00561	0.00561	CcSEcCtD
Goserelin—Affect lability—Thalidomide—leprosy	0.00561	0.00561	CcSEcCtD
Goserelin—Psychotic disorder—Thalidomide—leprosy	0.00557	0.00557	CcSEcCtD
Goserelin—Mood swings—Thalidomide—leprosy	0.0054	0.0054	CcSEcCtD
Goserelin—Tachycardia—Dapsone—leprosy	0.00534	0.00534	CcSEcCtD
Goserelin—Dry skin—Thalidomide—leprosy	0.00522	0.00522	CcSEcCtD
Goserelin—Breast disorder—Thalidomide—leprosy	0.00515	0.00515	CcSEcCtD
Goserelin—Insomnia—Dapsone—leprosy	0.00495	0.00495	CcSEcCtD
Goserelin—Influenza—Thalidomide—leprosy	0.00493	0.00493	CcSEcCtD
Goserelin—Angina pectoris—Thalidomide—leprosy	0.0048	0.0048	CcSEcCtD
Goserelin—Bronchitis—Thalidomide—leprosy	0.00474	0.00474	CcSEcCtD
Goserelin—Upper respiratory tract infection—Thalidomide—leprosy	0.00458	0.00458	CcSEcCtD
Goserelin—Pollakiuria—Thalidomide—leprosy	0.00455	0.00455	CcSEcCtD
Goserelin—Erectile dysfunction—Thalidomide—leprosy	0.00454	0.00454	CcSEcCtD
Goserelin—Photosensitivity reaction—Thalidomide—leprosy	0.0045	0.0045	CcSEcCtD
Goserelin—Weight increased—Thalidomide—leprosy	0.00448	0.00448	CcSEcCtD
Goserelin—Gastrointestinal pain—Dapsone—leprosy	0.00448	0.00448	CcSEcCtD
Goserelin—Hyperglycaemia—Thalidomide—leprosy	0.00444	0.00444	CcSEcCtD
Goserelin—Pneumonia—Thalidomide—leprosy	0.00442	0.00442	CcSEcCtD
Goserelin—Drowsiness—Thalidomide—leprosy	0.00439	0.00439	CcSEcCtD
Goserelin—Depression—Thalidomide—leprosy	0.00438	0.00438	CcSEcCtD
Goserelin—Acute coronary syndrome—Thalidomide—leprosy	0.00433	0.00433	CcSEcCtD
Goserelin—Body temperature increased—Dapsone—leprosy	0.00433	0.00433	CcSEcCtD
Goserelin—Abdominal pain—Dapsone—leprosy	0.00433	0.00433	CcSEcCtD
Goserelin—Renal failure—Thalidomide—leprosy	0.00432	0.00432	CcSEcCtD
Goserelin—Myocardial infarction—Thalidomide—leprosy	0.00431	0.00431	CcSEcCtD
Goserelin—Sweating—Thalidomide—leprosy	0.00421	0.00421	CcSEcCtD
Goserelin—Haematuria—Thalidomide—leprosy	0.00419	0.00419	CcSEcCtD
Goserelin—Epistaxis—Thalidomide—leprosy	0.00414	0.00414	CcSEcCtD
Goserelin—Sinusitis—Thalidomide—leprosy	0.00412	0.00412	CcSEcCtD
Goserelin—Rhinitis—Thalidomide—leprosy	0.00395	0.00395	CcSEcCtD
Goserelin—Hepatitis—Thalidomide—leprosy	0.00394	0.00394	CcSEcCtD
Goserelin—Pharyngitis—Thalidomide—leprosy	0.00391	0.00391	CcSEcCtD
Goserelin—Urinary tract disorder—Thalidomide—leprosy	0.00389	0.00389	CcSEcCtD
Goserelin—Oedema peripheral—Thalidomide—leprosy	0.00388	0.00388	CcSEcCtD
Goserelin—Urethral disorder—Thalidomide—leprosy	0.00387	0.00387	CcSEcCtD
Goserelin—Eye disorder—Thalidomide—leprosy	0.00369	0.00369	CcSEcCtD
Goserelin—Cardiac disorder—Thalidomide—leprosy	0.00366	0.00366	CcSEcCtD
Goserelin—Angiopathy—Thalidomide—leprosy	0.00358	0.00358	CcSEcCtD
Goserelin—Immune system disorder—Thalidomide—leprosy	0.00356	0.00356	CcSEcCtD
Goserelin—Chills—Thalidomide—leprosy	0.00354	0.00354	CcSEcCtD
Goserelin—Arrhythmia—Thalidomide—leprosy	0.00352	0.00352	CcSEcCtD
Goserelin—Alopecia—Thalidomide—leprosy	0.00348	0.00348	CcSEcCtD
Goserelin—Vomiting—Dapsone—leprosy	0.00348	0.00348	CcSEcCtD
Goserelin—Mental disorder—Thalidomide—leprosy	0.00345	0.00345	CcSEcCtD
Goserelin—Malnutrition—Thalidomide—leprosy	0.00343	0.00343	CcSEcCtD
Goserelin—Headache—Dapsone—leprosy	0.00343	0.00343	CcSEcCtD
Goserelin—Flatulence—Thalidomide—leprosy	0.00338	0.00338	CcSEcCtD
Goserelin—Tension—Thalidomide—leprosy	0.00337	0.00337	CcSEcCtD
Goserelin—Nervousness—Thalidomide—leprosy	0.00333	0.00333	CcSEcCtD
Goserelin—Back pain—Thalidomide—leprosy	0.00332	0.00332	CcSEcCtD
Goserelin—Muscle spasms—Thalidomide—leprosy	0.0033	0.0033	CcSEcCtD
Goserelin—Nausea—Dapsone—leprosy	0.00325	0.00325	CcSEcCtD
Goserelin—Vision blurred—Thalidomide—leprosy	0.00324	0.00324	CcSEcCtD
Goserelin—Ill-defined disorder—Thalidomide—leprosy	0.00319	0.00319	CcSEcCtD
Goserelin—Anaemia—Thalidomide—leprosy	0.00317	0.00317	CcSEcCtD
Goserelin—Malaise—Thalidomide—leprosy	0.0031	0.0031	CcSEcCtD
Goserelin—Leukopenia—Thalidomide—leprosy	0.00307	0.00307	CcSEcCtD
Goserelin—Palpitations—Thalidomide—leprosy	0.00303	0.00303	CcSEcCtD
Goserelin—Cough—Thalidomide—leprosy	0.003	0.003	CcSEcCtD
Goserelin—Convulsion—Thalidomide—leprosy	0.00297	0.00297	CcSEcCtD
Goserelin—Hypertension—Thalidomide—leprosy	0.00296	0.00296	CcSEcCtD
Goserelin—Chest pain—Thalidomide—leprosy	0.00292	0.00292	CcSEcCtD
Goserelin—Myalgia—Thalidomide—leprosy	0.00292	0.00292	CcSEcCtD
Goserelin—Arthralgia—Thalidomide—leprosy	0.00292	0.00292	CcSEcCtD
Goserelin—Anxiety—Thalidomide—leprosy	0.00291	0.00291	CcSEcCtD
Goserelin—Unspecified disorder of skin and subcutaneous tissue—Thalidomide—leprosy	0.0029	0.0029	CcSEcCtD
Goserelin—Discomfort—Thalidomide—leprosy	0.00289	0.00289	CcSEcCtD
Goserelin—Dry mouth—Thalidomide—leprosy	0.00286	0.00286	CcSEcCtD
Goserelin—Confusional state—Thalidomide—leprosy	0.00282	0.00282	CcSEcCtD
Goserelin—Oedema—Thalidomide—leprosy	0.0028	0.0028	CcSEcCtD
Goserelin—Infection—Thalidomide—leprosy	0.00278	0.00278	CcSEcCtD
Goserelin—Shock—Thalidomide—leprosy	0.00276	0.00276	CcSEcCtD
Goserelin—Nervous system disorder—Thalidomide—leprosy	0.00275	0.00275	CcSEcCtD
Goserelin—Thrombocytopenia—Thalidomide—leprosy	0.00274	0.00274	CcSEcCtD
Goserelin—Tachycardia—Thalidomide—leprosy	0.00273	0.00273	CcSEcCtD
Goserelin—Skin disorder—Thalidomide—leprosy	0.00272	0.00272	CcSEcCtD
Goserelin—Hyperhidrosis—Thalidomide—leprosy	0.00271	0.00271	CcSEcCtD
Goserelin—Anorexia—Thalidomide—leprosy	0.00267	0.00267	CcSEcCtD
Goserelin—Hypotension—Thalidomide—leprosy	0.00262	0.00262	CcSEcCtD
Goserelin—Musculoskeletal discomfort—Thalidomide—leprosy	0.00255	0.00255	CcSEcCtD
Goserelin—Insomnia—Thalidomide—leprosy	0.00253	0.00253	CcSEcCtD
Goserelin—Paraesthesia—Thalidomide—leprosy	0.00252	0.00252	CcSEcCtD
Goserelin—Dyspnoea—Thalidomide—leprosy	0.0025	0.0025	CcSEcCtD
Goserelin—Somnolence—Thalidomide—leprosy	0.00249	0.00249	CcSEcCtD
Goserelin—Dyspepsia—Thalidomide—leprosy	0.00247	0.00247	CcSEcCtD
Goserelin—Decreased appetite—Thalidomide—leprosy	0.00244	0.00244	CcSEcCtD
Goserelin—Fatigue—Thalidomide—leprosy	0.00242	0.00242	CcSEcCtD
Goserelin—Pain—Thalidomide—leprosy	0.0024	0.0024	CcSEcCtD
Goserelin—Constipation—Thalidomide—leprosy	0.0024	0.0024	CcSEcCtD
Goserelin—Feeling abnormal—Thalidomide—leprosy	0.00231	0.00231	CcSEcCtD
Goserelin—Gastrointestinal pain—Thalidomide—leprosy	0.00229	0.00229	CcSEcCtD
Goserelin—Urticaria—Thalidomide—leprosy	0.00223	0.00223	CcSEcCtD
Goserelin—Body temperature increased—Thalidomide—leprosy	0.00221	0.00221	CcSEcCtD
Goserelin—Abdominal pain—Thalidomide—leprosy	0.00221	0.00221	CcSEcCtD
Goserelin—Hypersensitivity—Thalidomide—leprosy	0.00206	0.00206	CcSEcCtD
Goserelin—Asthenia—Thalidomide—leprosy	0.00201	0.00201	CcSEcCtD
Goserelin—Pruritus—Thalidomide—leprosy	0.00198	0.00198	CcSEcCtD
Goserelin—Diarrhoea—Thalidomide—leprosy	0.00192	0.00192	CcSEcCtD
Goserelin—Dizziness—Thalidomide—leprosy	0.00185	0.00185	CcSEcCtD
Goserelin—Vomiting—Thalidomide—leprosy	0.00178	0.00178	CcSEcCtD
Goserelin—Rash—Thalidomide—leprosy	0.00177	0.00177	CcSEcCtD
Goserelin—Dermatitis—Thalidomide—leprosy	0.00176	0.00176	CcSEcCtD
Goserelin—Headache—Thalidomide—leprosy	0.00176	0.00176	CcSEcCtD
Goserelin—Nausea—Thalidomide—leprosy	0.00166	0.00166	CcSEcCtD
